It showed that Korlym improved glucose control in patients with hypercortisolism (Cushing’s syndrome) and difficult-to-control type 2 diabetes.

From our earliest days in medical school, we learned that treatment requires a patient’s informed consent. What is less often taught is how to obtain that consent in a manner that withstands legal ...

Metabolic and bariatric surgery is associated with higher incidence of minor complications for Black vs White patients.

One man was turned down for a transplant due to his weight, but found new life at the Mayo Clinic. Mandy Gaither reports in this week’s Health Minute, sponsored by St. Francis Health.

June 26 (Reuters) - Novo Nordisk (NOVOb.CO) said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.